Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Erythromelalgia: From Diagnosis to Treatment of Pediatric and Adult Patients
Description
The discussion on erythromelalgia focuses on the complexities of diagnosing and treating this chronic pain syndrome in both pediatric and adult patients. The presentation emphasizes that treatment typically involves off-label medications that can be challenging and require a trial-and-error approach. A critical point raised is the need for patient education to set realistic expectations and emphasize the importance of lifestyle adjustments, particularly in managing pain and minimizing triggers. Swimming is recommended as a beneficial exercise due to its cooling effects. Treatment options include topical medications like amitriptyline and ketamine, which have shown promise in controlling pain, and other agents like gabapentin and capsaicin. The role of systemic medications such as aspirin, gabapentin, and beta blockers is also explored, highlighting different patient responses. The speaker notes the importance of modifying existing treatments when necessary, such as discontinuing calcium channel blockers that can worsen symptoms. The discussion also touches on emerging therapies, including new medications targeting specific nerve channels and innovative procedural interventions like scramble therapy. The lecture concludes by showcasing the need for a comprehensive and multidisciplinary approach to optimize treatment outcomes for patients with erythromelalgia.
View moreConclusions
- Erythromelalgia is a chronic, debilitating pain syndrome that is largely incurable for most patients.
- Management of erythromelalgia often involves multiple treatment modalities and cycles of trial and error.
- Topical treatments such as a combination of amitriptyline and ketamine demonstrate significant efficacy in 75% of patients.
- Swimming is recommended as a therapeutic exercise for its cool water and non-weight bearing attributes.
- Systemic treatments, including aspirin, gabapentin, and sodium channel blockers, have varying degrees of success but largely depend on individual circumstances.
- Corticosteroids may provide relief in specific subgroups of erythromelalgia patients, particularly in those with a sudden onset related to surgery or trauma.
- Patients on stimulant medications are likely to experience a higher number of symptomatic areas and facial involvement related to erythromelalgia.
- Anhidrosis is prevalent among erythromelalgia patients, particularly in older age and female sex, suggesting demographic characteristics can influence treatment approaches.
- Setting realistic expectations with patients is essential for effective management and patient satisfaction.
- Sandroni P, Davis MDP. Combination Gel of 1% Amitriptyline and 0.5% Ketamine to Treat Refractory Erythromelalgia Pain: A New Treatment Option? Arch Dermatol. 2006;142(3):283-286.
- Poterucha TJ, Weiss WT, Warndahl RA, Rho RH, Sandroni P, Davis MD, Murphy SL. Topical amitriptyline combined with ketamine for the treatment of erythromelalgia: a retrospective study of 36 patients at Mayo Clinic. J Drugs Dermatol. 2013 Mar;12(3):308-10. PMID: 23545913.
- Davis MD, Morr CS, Warndahl RA, Sandroni P. Topically Applied Midodrine, 0.2%, an a1-Agonist, for the Treatment of Erythromelalgia. JAMA Dermatol. 2015 Sep;151(9):1025-6. doi:10.1001/jamadermatol.2015.0511. PMID: 25946117.
- Pagani-Estévez GL, Sandroni P, Davis MD, Watson JC. Erythromelalgia: Identification of a corticosteroid-responsive subset. J Am Acad Dermatol. 2017 Mar;76(3):506-511.e1. Epub 2016 Oct 26. PMID: 28413058.
- Ziebart RL, Coon EA, Sartori-Valinotti JC. Role of thermoregulatory sweat test in the diagnosis of facial flushing: A retrospective case series. J Am Acad Dermatol. 2024 Apr;90(4):841-842. PMID: 38065321.